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Abstract Biomedical scientific research in the Nether-
lands has a good reputation worldwide. Quantitatively, the
university medical centres (UMCs) deliver about 40 % of
the total number of scientific publications of this research.
Analysis of the bibliometric output data of the UMCs shows
that their research is highly cited. These output-based anal-
yses also indicate the high impact of cardiovascular scien-
tific research in these centres, illustrating the strength of
this research in the Netherlands. A set of six joint national
cardiovascular research topics selected by the UMCs can
be recognised. At the top are heart failure, rhythm disor-
der research and atherosclerosis. National collaboration of
top scientists in consortia in these three areas is successful
in acquiring funding of large-scale programs. Our obser-
vations suggest that funding national consortia of experts
focused on a few selected research topics may increase the
international competitiveness of cardiovascular research in
the Netherlands.
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Introduction
The Netherlands has a good reputation worldwide when
it comes to biomedical and medical scientific research,
most of which takes place in the university medical cen-
tres (UMCs). The scientific output of that research can be
estimated both quantitatively and qualitatively. Quantita-
tively, UMCs deliver about 40 % of the total number of
scientific publications in the Netherlands [1]. In compari-
son with other countries, they publish the highest number
of scientific articles per million euros of research budget
invested [2, http://www.nfu.nl/wetenschap/]. Qualitatively,
peer judgments are generally used. Besides that, a suitable
indicator of the quality of the output could be derived from
bibliometric analysis: the number of times a publication is
referred to gives an indication of use by scientists at the re-
search front, as they build on previous work. For the period
2007–2011/2012 the publications of the UMCs were on av-
erage cited 56 % more, compared with the world citation
average [3].
Cardiovascular scientific research is a branch of this sci-
ence. Besides a bibliometric analysis of the output of that
research, the present study deals with some thematic as-
pects of cardiovascular scientific research in the UMCs in
the Netherlands.
Background information
On a regular basis the UMCs deliver their annual scien-
tific output to the Centre for Science & Technology Studies
(CWTS) and ask this centre to analyse these data on an
overall level based on a comparison of the output in jour-
nals covered by Thomson Reuters in their Web of Science.
Several indicators may be important in a bibliometric anal-
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Table 1 Field-normalised impact score (MNCS) in three categories: all journal subject categories (JSCs) combined, JSC cardiac and cardio-
vascular systems and JSC peripheral vascular diseases for eight UMCs for the period 2007–2011. The total number of fields characteristic for the
research profile of each UMC (CWTS report Bibliometric study on Dutch academic medical centers 1998–2011/2012, Figs 1b–8b [3]), is also
presented as well as the position of the two relevant cardiovascular JSCs in this total number of fields.
UMC Field normalised impact score (MNCS) Research profile of UMC
All fields
combined
Cardiac &
cardiovascular
systems
Peripheral
vascular
diseases
Total fieldsa Position of the JSC in the total number
of fields within the UMC
Cardiac & cardio-
vascular systems
Peripheral vas-
cular diseases
Erasmus MC 1.67 1.61 1.44 28 2 14
LUMC 1.65 1.80 1.40 29 2 13
Radboudumc 1.58 1.50 1.35 33 29 31
Maastricht
UMC+
1.55 1.96 1.37 32 2 3
UMC Groningen 1.48 1.38 1.10 31 1 18
UMC Utrecht 1.65 1.68 1.38 29 4 6
AMC 1.56 1.64 1.42 31 1 11
VUMC 1.70 1.77 1.40 32 10 21
aIn the profiles we only showed those JSCs with over 1 % of the output of the respective UMC
ysis as they relate to different aspects of publication and
citation characteristics [3]. Generally, the field-normalised
impact score, MNCS, is considered to be a powerful inter-
nationally standardised impact indicator for analysing re-
search performance [4, 5]. This impact indicator is defined
as ‘The impact of a set of research articles, compared with
the world citation average in the subfields in which these
research papers have appeared’.
Bibliometric analysis
In this analysis we used the data published in the CWTS
report Bibliometric study on Dutch academic medical cen-
tres 1998–2011/2012 (http://www.nfu.nl/img/pdf/14.1790_
CWTS_Analyse_1998-2011.2012.pdf) [3]. This report is
publicly available while the raw data of this report can be
derived from the Web of Science. Analysing the bibliomet-
ric output data of the UMCs during the period 2007–2011
[3] we create a cardiovascular research profile for each
UMC. In that output-based profile two journal subject cat-
egories (JSCs) are most characteristic, namely Cardiac &
Cardiovascular Systems and Peripheral Vascular Diseases.
These two JSCs are considered to include the most char-
acteristic and specific journals for publishing results of re-
search dealing with the heart and blood vessels. The JSC
Haematology is not included, because it covers more re-
search that can be related to other types of disease (such as
oncology) and to more basic scientific research. However,
it is very important to keep in mind that the cardiovascular
research profiles only display information on the output and
impact per UMC in the two above-mentioned JSCs. You
have to realise that these profiles do not provide informa-
tion on the level of organisational units within a UMC (for
instance cardiovascular institutes or departments within a
UMC), as there is no direct organic link between the units
producing papers and the JSCs these papers belong to [6].
Fig. 9 in the CWTS report [3] displays the research pro-
file for the combined output of the UMCs. The overall
MNCS of this output is 1.56 and that of the JSC Cardiac
& Cardiovascular Systems is 1.64. The MNCS of the JCS
Peripheral Vascular Diseases is 1.38. In Table 1 the overall
MNCS scores in the three categories for the eight UMCs
in the Netherlands are presented for the period 2007–2011.
All these data indicate the strong position of the medi-
cal centres in the international biomedical scientific arena:
their research is highly cited. The data for the two relevant
cardiovascular categories show a high impact as well, illus-
trating the strength of the cardiovascular scientific research
in the Netherlands.
With respect to the JSC Peripheral Vascular Diseases we
observe MNCS scores of 35 % to 44 % compared with the
worldwide average impact level. These scores indicate a
highly cited vascular-oriented research field in the Nether-
lands. Only one UMC has a somewhat lower impact as
compared with the other seven UMCs. In the JSC Cardiac
& Cardiovascular Systems the MNCS scores vary between
1.96 (Maastricht UMC+) and 1.38 (UMC Groningen), in-
dicating that cardiac research in the Netherlands is also
highly cited. However, the variations in impact between
the eight UMCs are apparently more pronounced in this
research field than in the vascular-oriented research field.
In general, between 7.7 % and 9.9 % of the output of
a UMC is displayed in its cardiovascular research profile.
Exceptions are Radboudumc Nijmegen (2.4 %) and VUMC
Amsterdam (4.4 %). Looking at the data of Table 1 we
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Table 2 Overview of the locations studying cardiovascular diseases as described in the information of the eight university medical centres (status
April 2014) in the Netherlands; the locations of atherosclerosis research are also indicated
University Medical Centre
Maastricht
UMC+
Erasmus
MC
LUMC VUMC AMC UMC
Utrecht
UMC
Gronin-
gen
Radboud
umc
Cardiovascular disease
Atherothrombosis/thrombosis X X X X X
Cardiac hypertrophy/ heart
failure
X X X X X X X
Atrial fibrillation X X X X
Arrhythmias X X X X
Stroke X X X
Acute coronary syndromes X X X X X
Congenital heart diseases X X X X X
Pulmonary hypertension X X
Heart diseases/vascular as-
pects and pregnancy
X X
Diabetes mellitus X X X X
Valvular diseases X
Atherosclerosis X X X X X X X X
can distinguish several types of cardiovascular research pro-
files. Maastricht UMC+ has a very high citation score and
a strong cardiovascular research profile. Although UMC
Utrecht has a lower citation score its cardiovascular research
profile may be compared with Maastricht. Three UMCs
(Erasmus MC Rotterdam, LUMC Leiden and AMC Am-
sterdam) have almost comparable cardiovascular research
profiles. Radboudumc does not have a strongly marked
cardiovascular research profile, but the research in question
has a reasonably high citation score. VUMC also has a
low cardiovascular research profile, but its cardiovascular
research has a high citation score. Compared with the other
UMCs, Table 1 also illustrates that UMC Groningen has a
somewhat different pattern with an average citation score.
Cardiovascular research topics
Analysing the bibliometric data of the UMCs, it is interest-
ing to involve the cardiovascular research topics chosen by
the respective centres. In April 2014 the websites and the
annual reports of the eight UMCs were consulted. In Maas-
tricht cardiovascular research is clustered in the School for
Cardiovascular Diseases (CARIM), one of the top institutes
for translational cardiovascular research in Europe. In Eras-
mus MC that research is organised in COEUR and at the
VUMC in the Institute for Cardiovascular Research (ICaR-
VU). The research program Circulatory Health comprises
the cardiovascular research in the UMC Utrecht. In Rad-
boudumc, the Radboud Institute for Molecular Life Sci-
ences (RIMLS) and the Radboud Institute for Health Sci-
ences (RIHS) both distinguish a research theme Vascular
Damage. The AMC (Amsterdam) has three cardiovascu-
lar key research topics and houses the AMC Heart Failure
Research Centre and the Durrer Centre for Cardiogenetic
Research. In Groningen the UMC has organised its research
in five Research Institutes. One of them (GUIDE) distin-
guishes the Preservation of Cardiac Function over Time
(GUIDE-CVC) program and the Vascular Ageing program
(GUIDE-VAP). In Leiden the LUMC has chosen seven
medical research profiles, one of which is Vascular and
Regenerative Medicine. The Cardiology Department of
LUMC mentions two research topics. In Leiden there is
also an inter-faculty working group, the Leiden Vascular
Medicine, for coronary atherosclerosis. Because the level
of the information on cardiovascular research presented by
the eight different locations varies substantially it is nearly
impossible to give a complete and detailed overview of the
cardiovascular research in the Netherlands. At the level
of cardiovascular research themes defined as a fair number
of connected research projects, a sufficient critical mass of
investigators and sufficient output, the results of the analy-
sis are presented in Table 2. This analysis focuses on the
cardiovascular diseases specifically mentioned in the infor-
mation consulted as well as aspects of atherosclerosis.
Cardiac hypertrophy/heart failure research is a national
research topic studied in seven of the eight UMCs. Rhythm
disorders are studied in six centres: especially research
into ventricular fibrillation in four centres and atrial fib-
rillation research also in four locations. Atherothrombosis/
thrombosis, congenital heart diseases and acute coronary
syndromes are topics in five medical centres. The other car-
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Table 3 Multicentre-related cardiovascular research in national funding programs and consortium leadership at the European level
University Medical Centre
Maastricht
UMC+
Erasmus
MC
LUMC VUMC AMC UMC
Utrecht
UMC
Gronin-
gen
Radboud
umc
Heart failure
CTMM TRIUMPH X X X X
CVON ARENA X X X X X
Europa MEDIA X
Eurostat BIOSTAT-CHG X
Rhythm disorders
CTMM COHFAR X X X X
CVON PREDICT X X X X
Thrombosis
CTMM INCOAG X X X
Congenital heart diseases
Europa HEART REPAIR X
Europa CHEARTED X
diovascular diseases described in Table 2 are studied in four
or less university centres. All UMCs contribute to unravel
mechanisms of atherosclerosis and accelerate therapeutic
applications in vascular medicine. This analysis clearly ac-
centuates a set of six joint cardiovascular research topics of
the eight UMCs.
International and national competitiveness
Taking into account the cardiovascular research topics, the
question that arises is whether top Dutch scientists in each
field compete with each other for research funding or col-
laborate to unravel mechanisms underlying the cardiovascu-
lar diseases. And have the investigators already succeeded
in establishing multicentre-related research programs? To
answer these questions we analysed cardiovascular partici-
pation in two large national funding programs and the par-
ticipation of Dutch cardiovascular scientists as consortium
leaders at the European level.
Partly with funding from the natural gas reserve (FES
2006), three Dutch technological institutes were estab-
lished. One of these institutes, CTMM (Centre for Trans-
lational Molecular Medicine) bundles top research groups
in universities, knowledge institutes and UMCs with global
companies, medium-sized enterprises as well as high tech
start-ups, to improve therapies and give a boost to life
sciences research and development. The Netherlands Car-
dioVascular Research Initiative (CVON) encourages top
scientists to collaborate in national consortia and choose
topics that should address the problems encountered in the
care of cardiovascular patients [7]. In 2011 and 2013, seven
CVON programs were awarded [8, 9]. Consortium leaders
at the European level are looked for in the databases of
the European Commission for the period 2007–half 2011
(status June 2012).
The results of this analysis are presented in Table 3.
This table illustrates the strong position of the two national
topics heart failure and rhythm disorders research. In these
fields, scientists successfully collaborated and joined forces.
In thrombosis research the national collaboration still in-
creases. The remarkable success of research in congenital
heart diseases at the European level was apparently due to
a few top basic scientists. Our analysis showed that the
topic acute coronary syndromes is not yet successful at this
level. The strength of Dutch research into vascular and
thrombotic disorders is also evident: CTMM CIRCULAT-
ING CELLS and CTMM PARISK, CVON GENIUS and
CVON IN-CONTROL, Europe EU-PACT (UMC Utrecht)
and EU-PHASE (LUMC). The analysis clearly shows that
the increasing cooperation of investigators within the top of
the selected topics of cardiovascular research in the Nether-
lands is successful in the international and national compe-
tition for funding.
Conclusions and summary
Biomedical scientific research in the Netherlands has a
worldwide reputation. A branch of this science is the highly
cited cardiovascular research of the eight UMCs. A set
of six joint national cardiovascular research topics chosen
by the UMCs can be recognised. It appears that for the
top of these topics (heart failure, rhythm disorders research
and atherosclerosis) collaboration of top scientists in na-
tional consortia is successful in acquiring funding of large-
scale multicentre research programs. These observations
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may suggest that funding national consortia composed of
experts and focused on a few selected research topics ad-
dressing the problems encountered in cardiovascular patient
care can increase the international profile of Dutch cardio-
vascular research and its international competitiveness.
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